Yasmin Hurd, PhD
Ward-Coleman Chair of Translational Neuroscience
Director of the Addiction Institute at Mount Sinai
Mount Sinai Health System
Ward-Coleman Chair of Translational Neuroscience
Director of the Addiction Institute at Mount Sinai
Mount Sinai Health System
Related Videos
The Future of Addiction Treatment: CBD, Big Data, Adolescents, and Telehealth
Eric Nestler, MD, PhD, moderates 20-minute talks from Yasmin Hurd, PhD; Xiaosi Gu, PhD; Kara Bagot, MD; and Timothy Brennan, MD, MPH. You'll hear about what we know, what we're learning, and how we're implementing what we learn about substance abuse
From Party to Prescription: How Psychedelics Are Changing Traditional Psychiatry
Listen as Mount Sinai neuroscientists discuss ketamine, cannabis, and ecstasy as potential treatments for treatment-resistant depression, opioid addiction, and post-traumatic stress disorder
CBD for Treating Opioid Addiction
Dr. Hurd’s latest study showed that CBD reduces cravings and anxiety in patients with heroin use disorder.